Reliant Pharmaceuticals to Present at 25th Annual JPMorgan Healthcare Conference
Posted on: Wednesday, 3 January 2007, 09:01 CST
LIBERTY CORNER, N.J., Jan. 3 /PRNewswire/ -- Reliant Pharmaceuticals, Inc. today announced that Ernest Mario, Ph.D., the company's Chairman and Chief Executive Officer, will present at the 25th Annual JPMorgan Healthcare Conference on Monday, January 8 at 2:00 PM Pacific. The conference is being held at the Westin St. Francis Hotel in San Francisco.
Dr. Mario will provide an overview of Reliant and an update on the company's product portfolio.
About Reliant Pharmaceuticals, Inc.
Reliant Pharmaceuticals is a pharmaceutical company with integrated sales, marketing and development expertise that markets a portfolio of branded cardiovascular pharmaceutical products. Reliant focuses on marketing promotionally sensitive pharmaceutical products to the high prescribing primary care, cardiovascular and specialist physician markets in the United States. Reliant also acquires rights to and develops product candidates in mid- to late-stage clinical development. Reliant's sales force infrastructure is comprised of approximately 825 sales professionals nationwide.
"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995. To the extent any statements made in this release contain information that is not historical, these statements are essentially forward looking and are subject to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission.
Reliant Pharmaceuticals, Inc.
CONTACT: Marylou Rowe, Investor Relations Manager, ReliantPharmaceuticals, Inc., +1-908-860-4646, investorrelations@reliantrx.com
Web site: http://www.reliantrx.com/
Source: PRNewswire
Related Articles
- Radio Industry Leaders Team to Improve Marketing Mix Models to Demonstrate the Impact of Radio Advertising on Product Sales
- Six Products of Telestone Have Been Selected into 'The 3rd Catalog of the Self-Developed Products in Beijing City'
- Saft and ESMA to Cooperate on Supercapacitor Development, Production and Commercialization
- CIQUAL Secures GBP1.25M Investment to Accelerate Product Development and Sales of Unrivalled Mobile Broadband Performance and Customer Experience System
- Discovery Studios Names Sean Atkins Vice President of West Coast Production and Development
- Research and Markets: Manhattan Pharmaceuticals Inc New - Detailed Product Pipeline Report Available Now
- Diosynth Biotechnology Announces Agreement With VGX Pharmaceuticals for Process Development and Clinical Production of VGX-100 for the Treatment of Cancer
- Advancis Pharmaceutical Announces Preliminary 2006 Product Sales and Year-End Cash Position
- BigLever Software Introduces Gears 5.2(TM) to Streamline Early Stages of Portfolio Lifecycle Management; Gears 5.2 Enables the Integration of Requirements Management With Software Product Line Development to Reduce Time-to-Market and Production Costs
- Understanding New Product Co-Development Relationships In Technology- Based, Industrial Markets
 |
 |
User Comments (0)
RSS Feeds